High concentrations of cholecystokinin octapeptide suppress protein kinase C activity in guinea pig pancreatic acini

Peptides. 1996;17(6):917-25. doi: 10.1016/0196-9781(96)00139-8.

Abstract

In pancreatic acini, calcium-mobilizing agents increase intracellular calcium and stimulate the production of diacylglycerol, and then activate protein kinase C (PKC). However, there are few studies which have examined the activation of PKC in intact acini. To examine the activation of PKC in intact acini by calcium-mobilizing agents, we measured the binding of [3H]phorbol-12,13-dibutyrate (PDBu) to intact acini. Acini were incubated with 10 nM [3H]PDBu at 25 degrees C with or without agents. The binding reactions were terminated by filtration. The filters were counted by a scintillation counter after washing. Acini possessed a single class of binding sites to PDBu, with Kd = 70 nM. CCK-8 and carbachol upregulated the binding affinity of PKC to PDBu in the acini. The ability of calcium-mobilizing agents to increase binding of [3H]PDBu to the acini had a close correlation to their ability to stimulate the amylase secretion from the acini, and higher concentrations of CCK-8 for amylase secretion suppressed binding of [3H]PDBu to the acini. 8Br-cAMP, 8Br-cGMP, and calcium ionophore did not inhibit the maximal activation of PKC induced by CCK-8. The calmodulin inhibitor W7 did not reverse the inhibitory effect of higher concentrations of CCK-8 on PKC activation. These results indicate that calcium-mobilizing agents upregulate the binding affinity of PKC to PDBu in intact acini, and that higher concentrations of CCK-8 for amylase secretion may activate the intracellular mechanism that inhibits PKC activity in acini. This inhibitory mechanism was mediated by some other mechanism other than cAMP-, cGMP-, calcium- and calmodulin-dependent mechanisms.

Publication types

  • Comparative Study

MeSH terms

  • 8-Bromo Cyclic Adenosine Monophosphate / pharmacology
  • Amylases / metabolism
  • Animals
  • Bombesin / pharmacology
  • Carbachol / pharmacology
  • Cricetinae
  • Cyclic AMP / metabolism
  • Cyclic GMP / analogs & derivatives
  • Cyclic GMP / pharmacology
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Enzyme Activation
  • Gastrointestinal Agents / pharmacology*
  • In Vitro Techniques
  • Male
  • Pancreas / drug effects*
  • Pancreas / enzymology
  • Phorbol 12,13-Dibutyrate / metabolism
  • Protein Binding
  • Protein Kinase C / drug effects*
  • Sincalide / antagonists & inhibitors
  • Sincalide / pharmacology*
  • Tetragastrin / pharmacology

Substances

  • Gastrointestinal Agents
  • Tetragastrin
  • 8-Bromo Cyclic Adenosine Monophosphate
  • 8-bromocyclic GMP
  • Phorbol 12,13-Dibutyrate
  • Carbachol
  • Cyclic AMP
  • Protein Kinase C
  • Amylases
  • Cyclic GMP
  • Sincalide
  • Bombesin